507 related articles for article (PubMed ID: 27387826)
1. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
2. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
3. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
4. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
5. Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool.
Tan CW; Tee HK; Lee MH; Sam IC; Chan YF
PLoS One; 2016; 11(9):e0162771. PubMed ID: 27617744
[TBL] [Abstract][Full Text] [Related]
6. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
Huang KA; Huang PN; Huang YC; Yang SL; Tsao KC; Chiu CH; Shih SR; Lin TY
PLoS Pathog; 2020 Sep; 16(9):e1008857. PubMed ID: 32936838
[TBL] [Abstract][Full Text] [Related]
7. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
8. A Polysaccharide Purified From
Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
Front Immunol; 2020; 11():561758. PubMed ID: 33117346
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ
Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825
[TBL] [Abstract][Full Text] [Related]
10. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
11. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
12. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
13. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
[TBL] [Abstract][Full Text] [Related]
14. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
15. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
[TBL] [Abstract][Full Text] [Related]
16. Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice.
Lin JY; Weng KF; Chang CK; Gong YN; Huang GJ; Lee HL; Chen YC; Huang CC; Lu JY; Huang PN; Chiang HJ; Chen CM; Shih SR
J Virol; 2021 Oct; 95(21):e0089721. PubMed ID: 34379497
[TBL] [Abstract][Full Text] [Related]
17. Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.
Huang SW; Tai CH; Fonville JM; Lin CH; Wang SM; Liu CC; Su IJ; Smith DJ; Wang JR
J Virol; 2015 Nov; 89(22):11500-6. PubMed ID: 26339057
[TBL] [Abstract][Full Text] [Related]
18. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
19. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
Liu CC; Wu SC; Wu SR; Lin HY; Guo MS; Yung-Chih Hu A; Chow YH; Chiang JR; Shieh DB; Chong P
Vaccine; 2018 May; 36(22):3134-3139. PubMed ID: 28274636
[TBL] [Abstract][Full Text] [Related]
20. Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region.
Kobayashi K; Nishimura H; Mizuta K; Nishizawa T; Chu ST; Ichimura H; Koike S
J Virol; 2021 Nov; 95(23):e0151521. PubMed ID: 34523967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
